Ethyl Vanillin Beta-d-glucopyranoside

Ethyl Vanillin Beta-d-glucopyranoside (CAS Number: 122397-96-0) is a synthetic flavoring compound that combines ethyl vanillin with a beta-d-glucopyranoside sugar moiety. Ethyl vanillin is a widely used synthetic aromatic compound structurally similar to natural vanillin but with enhanced flavor intensity. The glucopyranoside attachment creates a glycoside derivative, which is a common chemical modification in food flavoring technology that can alter taste perception, stability, or sensory release characteristics.

This additive functions as a flavoring agent or flavor adjuvant in food manufacturing. It is used to provide or enhance vanilla-like and aromatic flavoring notes in various food products. Flavor adjuvants are typically used in very small quantities to achieve desired taste profiles. The specific applications of this compound in commercial food products are limited, and it represents a specialized flavoring option within the broader category of synthetic vanilla substitutes and flavor enhancers used by the food industry.

According to FDA records, there are no reported adverse events associated with Ethyl Vanillin Beta-d-glucopyranoside, and no product recalls have been linked to this substance. The absence of adverse event reports and recalls suggests no documented safety concerns from consumer exposure in the United States marketplace.

However, it is important to note that this additive has not received FDA GRAS (Generally Recognized As Safe) status. GRAS status requires either substantial scientific evidence of safe use or a formal FDA petition with supporting safety data. The lack of GRAS determination does not necessarily indicate the substance is unsafe; rather, it reflects that formal regulatory review through the GRAS process has not been completed or granted. Many flavoring compounds function in food products without formal GRAS status, particularly those used in very limited quantities or specific applications.

The chemical structure—combining ethyl vanillin with a glucose moiety—suggests potential characteristics worth consideration. Ethyl vanillin itself is a known and widely-used synthetic flavoring. The glucopyranoside modification may influence bioavailability, metabolism, or sensory characteristics compared to the parent compound. Limited published scientific literature is available specifically addressing this particular derivative's safety profile in toxicological or clinical studies.

In the United States, Ethyl Vanillin Beta-d-glucopyranoside does not have FDA GRAS status. It may be used in food under FDA regulations for food additives, but its regulatory pathway and approval status require clarification through FDA guidance or submission records. The European Union's approval status and inclusion on the EU flavoring substances list would depend on formal assessment by EFSA (European Food Safety Authority) and subsequent regulatory decisions, which may differ from U.S. determinations.

Manufacturers using this substance in food products should verify compliance with applicable regulations in their target markets, as flavoring regulations vary internationally.

Published scientific literature specifically evaluating the safety, toxicology, or organoleptic properties of Ethyl Vanillin Beta-d-glucopyranoside is limited in publicly available databases. Safety assessments for flavoring compounds typically rely on structural similarity to known safe compounds, in vitro testing, animal studies, and computational toxicology models. The absence of reported adverse events and recalls provides some reassurance from post-market surveillance, though this does not replace formal pre-market safety testing data.

Comprehensive safety evaluation would ideally include absorption, distribution, metabolism, and excretion (ADME) studies, particularly given the glucopyranoside modification, which may affect how the body processes this compound compared to ethyl vanillin alone.